<code id='3151F0DCE9'></code><style id='3151F0DCE9'></style>
    • <acronym id='3151F0DCE9'></acronym>
      <center id='3151F0DCE9'><center id='3151F0DCE9'><tfoot id='3151F0DCE9'></tfoot></center><abbr id='3151F0DCE9'><dir id='3151F0DCE9'><tfoot id='3151F0DCE9'></tfoot><noframes id='3151F0DCE9'>

    • <optgroup id='3151F0DCE9'><strike id='3151F0DCE9'><sup id='3151F0DCE9'></sup></strike><code id='3151F0DCE9'></code></optgroup>
        1. <b id='3151F0DCE9'><label id='3151F0DCE9'><select id='3151F0DCE9'><dt id='3151F0DCE9'><span id='3151F0DCE9'></span></dt></select></label></b><u id='3151F0DCE9'></u>
          <i id='3151F0DCE9'><strike id='3151F0DCE9'><tt id='3151F0DCE9'><pre id='3151F0DCE9'></pre></tt></strike></i>

          focus

          focus

          author:focus    Page View:7
          Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT
          Adobe

          For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

          But don’t take their numbers as gospel, experts warned.

          advertisement

          “It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          New air purifier tech could be key to improving indoor air quality
          New air purifier tech could be key to improving indoor air quality

          AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

          read more
          Pioneering cancer drug will cost $475,000. Analysts call it a bargain
          Pioneering cancer drug will cost $475,000. Analysts call it a bargain

          VictorSeguraIbarraandRitaSerda,Ph.D.,NCI,NIHTheFoodandDrugAdministrationonWednesdayapprovedafuturist

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          Novo: Oral version of Ozempic leads to 15% weight loss

          LISELOTTESABROE/AFP/GettyImagesAnoralversionofsemaglutide,thedrugmarketedasOzempicandWegovy,ledtodra